Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 37
Debate-Style Session

17 - Debating Clinical Controversies in HIV

Thursday, September 30, 2021
12:30 PM - 1:45 PM EDT

    Debate Style Moderator(s)

  • Wendy Armstrong, MD

    Professor of Medicine
    Emory University
    Atlanta, GA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Debate Style Speaker(s)

  • Allison Agwu, MD, MSc

    Professor
    Johns Hopkins University
    Baltimore, MD, United States

    Gilead (Individual(s) Involved: Self): Other Financial or Material Support, scientific advisor, Scientific Research Study Investigator; Merck (Individual(s) Involved: Self): Advisor or Review Panel member, Scientific Research Study Investigator

  • Marwan Haddad, MD, MPH, AAHIVS

    Medical Director, Center for Key Populations
    Community Health Center Inc.
    Middletown, Connecticut, United States

    AbbVie Pharmaceuticals (Individual(s) Involved: Spouse/Partner): Board Member; Clinical Care Options (Individual(s) Involved: Spouse/Partner): Speakers' bureau; Gilead Foundation (Individual(s) Involved: Spouse/Partner): Grant/Research Support; Gilead Sciences (Individual(s) Involved: Spouse/Partner): Board Member, Speakers' bureau; Merck Pharmaceuticals (Individual(s) Involved: Spouse/Partner): Board Member, Research Grant or Support, Speakers' bureau; NIAAA (Individual(s) Involved: Spouse/Partner): Grant/Research Support; NIDA (Individual(s) Involved: Spouse/Partner): Grant/Research Support; NIH (Individual(s) Involved: Spouse/Partner): Research Grant or Support; SAMHSA (Individual(s) Involved: Spouse/Partner): Grant/Research Support; Simply Speaking HIV (Individual(s) Involved: Spouse/Partner): Speakers' bureau

  • Kristine Erlandson, MD MS

    Associate Professor
    Department of Medicine, Divisions Infectious Diseases & Geriatric Medicine
    University of Colorado Anschutz Medical Campus
    Aurora, CO, United States

    Gilead Sciences (Individual(s) Involved: Self): Research Grant or Support; Janssen Pharmaceuticals (Individual(s) Involved: Self): Advisor or Review Panel member; Theratechnologies (Individual(s) Involved: Self): Advisor or Review Panel member; ViiV (Individual(s) Involved: Self): Advisor or Review Panel member

  • Darcy Wooten, MD, MS

    Associate Professor of Medicine, Division of Infectious Diseases and Global Public Health
    University of California, San Diego
    San Diego, CA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:
Wendy Armstrong, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Allison Agwu, MD, MSc: Gilead (Individual(s) Involved: Self): Other Financial or Material Support, scientific advisor, Scientific Research Study Investigator; Merck (Individual(s) Involved: Self): Advisor or Review Panel member, Scientific Research Study Investigator
Marwan Haddad, MD, MPH, AAHIVS: AbbVie Pharmaceuticals (Individual(s) Involved: Spouse/Partner): Board Member; Clinical Care Options (Individual(s) Involved: Spouse/Partner): Speakers' bureau; Gilead Foundation (Individual(s) Involved: Spouse/Partner): Grant/Research Support; Gilead Sciences (Individual(s) Involved: Spouse/Partner): Board Member, Speakers' bureau; Merck Pharmaceuticals (Individual(s) Involved: Spouse/Partner): Board Member, Research Grant or Support, Speakers' bureau; NIAAA (Individual(s) Involved: Spouse/Partner): Grant/Research Support; NIDA (Individual(s) Involved: Spouse/Partner): Grant/Research Support; NIH (Individual(s) Involved: Spouse/Partner): Research Grant or Support; SAMHSA (Individual(s) Involved: Spouse/Partner): Grant/Research Support; Simply Speaking HIV (Individual(s) Involved: Spouse/Partner): Speakers' bureau
Kristine M. Erlandson, MD MS: Gilead Sciences (Individual(s) Involved: Self): Research Grant or Support; Janssen Pharmaceuticals (Individual(s) Involved: Self): Advisor or Review Panel member; Theratechnologies (Individual(s) Involved: Self): Advisor or Review Panel member; ViiV (Individual(s) Involved: Self): Advisor or Review Panel member
Darcy Wooten, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • assess the pros and cons of switching INSTIs in patients who develop metabolic syndrome
  • discuss the pros and cons of relying on telemedicine for prevention and care delivery

Presentations:

  • The Role of Telemedicine in the Future: Permanent Gamechanger or Not so Fast

    Debate Style Speaker: Marwan Haddad, MD, MPH, AAHIVS – Community Health Center, Inc.

  • The Role of Telemedicine in the Future: Permanent Gamechanger or Not so Fast

    Debate Style Speaker: Allison Agwu, MD, MSc – Johns Hopkins University

  • To Switch or Not to Switch: Instis and Metabolic Syndrome

    Debate Style Speaker: Kristine M. Erlandson, MD MS – University of Colorado Anschutz Medical Campus

  • To Switch or Not to Switch: Instis and Metabolic Syndrome

    Debate Style Speaker: Darcy Wooten, MD, MS – Division of Infectious Diseases, University of California, San Diego